Data table Spot rate: 110.99/$ 30-day forward rate: 110.59/$ 90-day forward rate: 109.39/$ 180-day forward rate: 108.19/$ Numata's WACC 8.71% Bio Tron's WACC 9.48% Click on the icon located on the top-right corner of the data table in order to copy its contents into a spreadsheet. BioTron Medical, Inc. Brent Bush, CFO of a medical device distributor, Bio Tron Medical, Inc., was approached by a Japanese customer, Numata, with a proposal to pay cash (in yen) for its typical orders of 12,600,000 every other month if it were given a 5.1% discount. Numata's current terms are 30 days with no discounts. Using the quotes and estimated cost of capital for Bio Tron Medical in the popup window, Bush will compare the proposal with covering yen payments with forward contracts. Should Brent Bush accept Numata's proposal? Assume a 360-day financial year. How much in U.S. dollars will Bio Tron Medical receive with the discount? (Round to the nearest cent.)